📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
Latest filing: 2026-08-25 12:34
0 analysed today
FollowTelegram
0
Today
151,859
All-time analysed
43,535
Positive
6,743
Negative
92,744
Neutral
8,769
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
1 announcement match the current filters (relevance ≥ 5).
Shelter Pharma Dispatches USD 139,200 Export Order to Sudan; Targets ₹50 Cr Opportunity
Shelter Pharma Limited has completed manufacturing and fully dispatched an export order worth USD 139,200 (~₹1.16 crore) to Taha Drugs & Chemicals Co. Ltd in Sudan. The shipment comprises Foliman Tablets and Joemega Capsules (nutraceutical products). Management noted that increasing repeat orders in Sudan present a target opportunity of approximately ₹50 crore from that market. The dispatched order represents roughly 1% of TTM revenue (₹124 crore).
Confidence: HIGH
What changedShelter Pharma completed 100% manufacturing and dispatch of a USD 139,200 export order to Sudan.
Why it mattersValidates overseas demand for its nutraceutical portfolio and expands its export footprint in East Africa.
Order Value: USD 139,200Dispatched Value: USD 139,200Pending Dispatch: NILEstimated Market Opportunity: ₹50 crore
📅 Short termIncremental revenue recognition for the current quarter, reinforcing export execution capabilities.
📈 Long termIf the company successfully scales repeat orders toward its ₹50 crore target in Sudan, it could meaningfully boost topline growth over the next 2-3 years.
⚠ Risk flags
- Geopolitical and foreign exchange risks specific to Sudan
- Promoter holding has decreased from 52.32% (Sep 2025) to 44.38% (May 2026)
Key Highlights
Successfully completed and dispatched export order valued at USD 139,200 to Sudan.
Shipment includes Foliman Tablets and Joemega Capsules under GMP-certified standards.
Nil balance value remains pending for this specific purchase order.
Company cited a potential market opportunity of approximately ₹50 crore in the Sudan nutraceutical market.
👀 What to Watch
Monitor upcoming quarterly results to see if international shipments translate into sustained margin expansion and if the larger ₹50 crore Sudan opportunity converts into firm purchase orders.
